Øyvind Holme,
Mette Kalager,
Michael Bretthauer,
Hans Olov Adami,
Lise Mørkved Helsingen,
Magnus Løberg
:
Ongoing Trials Will Not Determine the Comparative Effectiveness of Colorectal Cancer Screening Tests
Gastroenterology 2023
DOI
Henriette C. Jodal,
Paulina Wieszczy,
Dagmar Klotz,
Magnhild Herfindal,
Ishita Barua,
Petter Tag
et al.:
A Comparison of Risk Classification Systems of Colorectal Adenomas: A Case-Cohort Study
Jingru Yu,
Erle Refsum,
Paulina Wieszczy,
Lise Mørkved Helsingen,
Vera Perrin,
Amanda Högdén
et al.:
Risk of malignant lymphomas in patients with inflammatory bowel disease: a population-based cohort study
BMJ open gastroenterology 2023
DOI
Linan Zeng,
Shelly-Anne Li,
Mengting Yang,
Lijiao Yan,
Lise Mørkved Helsingen,
Michael Bretthauer
et al.:
Qualitative study of guideline panelists: innovative surveys provided valuable insights regarding patient values and preferences
Journal of Clinical Epidemiology 2023
DOI
Linan Zeng,
Lise Mørkved Helsingen,
Michael Bretthauer,
Thomas Agoritsas,
Per Olav Vandvik,
Reem A. Mustafa
et al.:
A novel framework for incorporating patient values and preferences in making guideline recommendations: guideline panel surveys
Journal of Clinical Epidemiology 2023
DOI
Eline Aurvoll Langeland,
Synne E. R. Pisani,
Mette Kalager,
Michael Bretthauer,
Lise Mørkved Helsingen
:
Følger Helsedirektoratets retningslinjer internasjonale standarder for troverdighet?
Tidsskrift for Den norske legeforening 2023
ARKIV /
DOI
Michael Bretthauer,
Paulina Wieszczy,
Magnus Løberg,
Michał Filip Kamiński,
Tarjei Fiskergård Werner,
Lise Mørkved Helsingen
et al.:
Estimated Lifetime Gained with Cancer Screening Tests: A Meta-Analysis of Randomized Clinical Trials
JAMA Internal Medicine 2023
DOI
Jingru Yu,
Erle Refsum,
Lise Mørkved Helsingen,
Trine Folseraas,
Alexander Ploner,
Paulina Wieszczy
et al.:
Risk of hepato-pancreato-biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: A population-based cohort study
United European Gastroenterology Journal (UEG Journal) 2022
ARKIV /
DOI
Jingru Yu,
Erle Refsum,
Vera Perrin,
Lise Mørkved Helsingen,
Paulina Wieszczy,
Magnus Løberg
et al.:
Inflammatory bowel disease and risk of adenocarcinoma and neuroendocrine tumors in the small bowel
Annals of Oncology 08. Mar 2022
DOI
Henriette C. Jodal,
Dagmar Klotz,
Magnhild Herfindal,
Ishita Barua,
Petter Tag,
Lise Mørkved Helsingen
et al.:
Long-term colorectal cancer incidence and mortality after adenoma removal in women and men
Alimentary Pharmacology and Therapeutics 2021
DOI
Juliet A. Usher-Smith,
Katie M. Mills,
Christiane Riedinger,
Catherine L. Saunders,
Lise Mørkved Helsingen,
Lyubov Lytvyn
et al.:
The impact of information about different absolute benefits and harms on intention to participate in colorectal cancer screening: A think-aloud study and online randomised experiment
Lise Mørkved Helsingen,
Magnus Løberg,
Erle Refsum,
Dagrun Kyte Gjøstein,
Paulina Wieszczy,
Ørjan Olsvik
et al.:
Covid-19 transmission in fitness centers in Norway - a randomized trial
Frederik E. Juul,
Henriette C. Jodal,
Ishita Barua,
Erle Refsum,
Ørjan Olsvik,
Lise Mørkved Helsingen
et al.:
Mortality in Norway and Sweden during the COVID-19 pandemic
Scandinavian Journal of Public Health 2021
ARKIV /
DOI
Linan Zeng,
Lise M. Helsingen,
Fernando Kenji Nampo,
Yuting Wang,
Linag Yao,
Reed Alexander Siemieniuk
et al.:
How do cancer screening guidelines trade off benefits versus harms and burdens of screening? A systematic survey
Lise M. Helsingen,
Erle Refsum,
Dagrun Kyte Gjøstein,
Magnus Løberg,
Michael Bretthauer,
Mette Kalager
et al.:
The COVID-19 pandemic in Norway and Sweden – threats, trust, and impact on daily life: a comparative survey
BMC Public Health 23. Oct 2020
ARKIV /
DOI
Lise M. Helsingen,
Linan Zeng,
Reed A.C. Siemieniuk,
Lyubov Lytvyn,
Per Olav Vandvik,
Thomas Agoritsas
et al.:
Establishing thresholds for important benefits considering the harms of screening interventions
Cesare Hassan,
Giulio Antonelli,
Jean-Marc Dumonceau,
Jaroslaw Regula,
Michael Bretthauer,
Stanislas Chaussade
et al.:
Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2020
Lise M. Helsingen,
Per Olav Vandvik,
Henriette C. Jodal,
Thomas Agoritsas,
Lyubov Lytvyn,
Joseph C. Anderson
et al.:
Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: A clinical practice guideline
Maaike Buskermolen,
Dayna R Cenin,
Lise M. Helsingen,
Gordon Guyatt,
Per Olav Vandvik,
Ulrike Haug
et al.:
Colorectal cancer screening with faecal immunochemical
testing, sigmoidoscopy or colonoscopy: a microsimulation
modelling study
Henriette C. Jodal,
Lise M. Helsingen,
Joseph C. Anderson,
Lyubov Lytvyn,
Per Olav Vandvik,
Louise Emilsson
:
Colorectal cancer screening with faecal testing, sigmoidoscopy or colonoscopy: a systematic review and network meta-analysis
Frederik Emil Juul,
Kjetil Kjeldstad Garborg,
Michael Bretthauer,
Hilde Kristin Skudal,
Mari N. Oines,
Håvard Wiig
et al.:
Fecal microbiota transplantation for primary Clostridium difficile infection
New England Journal of Medicine 2018
ARKIV /
DOI
Reed A.C. Siemieniuk,
Ian A. Harris,
Thomas Agoritsas,
Rudolf W. Poolman,
Brignardello-Petersen Romina,
Stijn Van De Velde
et al.:
Arthroscopic surgery for degenerative knee arthritis and meniscal tears: a clinical practice guideline
Mari Nanna Øines,
Lise M. Helsingen,
Michael Bretthauer,
Louise Emilsson
:
Epidemiology and risk factors of colorectal polyps
Baillière's Best Practice & Research : Clinical Gastroenterology 2017
DOI
Lise Mørkved Helsingen,
Eline Aurvoll Langeland,
Synne Eline Rotihaug Pisani,
Per Olav Vandvik,
Espen A. Haavardsholm,
Ulrik Fredrik Malt
et al.:
Glansbilder av nasjonale faglige retningslinjer fra Helsedirektoratet
Tidsskrift for Den norske legeforening 2024
DOI
Rasmus Gantzel,
Paulina Wieszczy,
Erle Refsum,
Tine Jess,
Lone Larsen,
Michael Bretthauer
et al.:
Prognostic models for colorectal cancer incidence and mortality in patients with inflammatory bowel disease
Cochrane Database of Systematic Reviews 2023
DOI
Einar Øverenget,
Mette Kalager,
Gunnveig Grødeland,
Ørjan Olsvik,
Anna Nylund,
Magnus Løberg
et al.:
Når smittevern blir uforståelig
Dagensnæringsliv 2022
Lise Mørkved Helsingen,
Magnus Løberg,
Michael Bretthauer,
Mette Kalager
:
Reply to: Letter to the Editor regarding "Covid-19 transmission in fitness centers in Norway-a randomized trial"
BMC Public Health 2022
DOI
Michael Bretthauer,
Lise Mørkved Helsingen,
Mette Kalager,
Per Olav Vandvik,
Thomas Agoritsas,
Gordon Guyatt
:
The future of colorectal cancer screening: Parentalism or shared decision-making?
CMAJ - Canadian Medical Association Journal 2020
DOI
Erle Refsum,
Lise M. Helsingen,
Henriette Cecilie Jodal,
Magnus Løberg,
Njål Høstmælingen,
Mette Kalager
:
Personvern – en hinderløype
Tidsskrift for Den norske legeforening 2019
DOI
Lise M. Helsingen,
Per Olav Vandvik,
Henriette C. Jodal,
Silje Bjerkelund Murphy,
Anja Fog Heen,
Mette Kalager
et al.:
Tarmkreftscreening, eller ikke?
Tidsskrift for Den norske legeforening 2019
DOI
Frederik Emil Juul,
Kjetil Kjeldstad Garborg,
Michael Bretthauer,
Mette Kalager,
Tore Midtvedt,
Siv Furholm
et al.:
Fecal microbiota transplantation versus antibiotics for primary Clostridium difficile infection - a multicenter, randomized proof-of-concept trial
2018
Mette Kalager,
Eirik M. Hagen,
Lise M. Helsingen
:
Farlig forretning på frykt
Dagens næringsliv 29. Nov 2016
Lise M. Helsingen
:
Ett år som medisinsk redaktør
Tidsskrift for Den norske legeforening 25. Aug 2015
DOI